12 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 30348903 | Mechanistic In Vitro Studies Indicate that the Clinical Drug-Drug Interaction between Telithromycin and Simvastatin Acid Is Driven by Time-Dependent Inhibition of CYP3A4 with Minimal Effect on OATP1B1. | 2019 Jan | 2 |
2 | 29469964 | Impact of SLCO1B1 Genotype on Pediatric Simvastatin Acid Pharmacokinetics. | 2018 Jun | 2 |
3 | 28350522 | The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition. | 2017 Apr | 2 |
4 | 25673568 | Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect? | 2015 Mar | 2 |
5 | 26020121 | SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid. | 2015 Aug | 1 |
6 | 26164721 | Individual and Combined Associations of Genetic Variants in CYP3A4, CYP3A5, and SLCO1B1 With Simvastatin and Simvastatin Acid Plasma Concentrations. | 2015 Jul | 1 |
7 | 26329790 | Clopidogrel Has No Clinically Meaningful Effect on the Pharmacokinetics of the Organic Anion Transporting Polypeptide 1B1 and Cytochrome P450 3A4 Substrate Simvastatin. | 2015 Nov | 1 |
8 | 26367500 | Impact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid. | 2015 Dec | 1 |
9 | 22538052 | Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins. | 2012 Aug 30 | 1 |
10 | 21245207 | Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. | 2011 Mar | 3 |
11 | 19785645 | Impact of OATP transporters on pharmacokinetics. | 2009 Oct | 6 |
12 | 17108811 | SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid. | 2006 Dec | 4 |